17Leishmania infantum infantum (LII) is one of the species that causes visceral 18 leishmaniasis (VL) in the Old World, while L. infantum chagasi (LIC), and is present 19 in the New World. Few studies address the biological differences, as well as the 20 behaviour of these strains during infection. These parasites live inside the cells of 21 their hosts, continuously evading the microbicidal mechanisms and modulating the 22 immune response of these cells. One of the mechanisms used by these protozoa 23 involves the L-arginine metabolism. Given the importance of the understanding of 2 24 differences between Leishmania species, as well as establishing a better murine 25 model to study leishmaniases, the objectives of this work were to analyse the 26 biological and molecular differences between two Leishmania infantum strains (LII 27 and LIC) and the degree of susceptibility of mice with different genetic backgrounds 28 to infection, as well as to understand the role of arginase (ARG)/nitric oxide synthase 29 (NOS) in the parasite-host relationship. The infectivity in vivo and in vitro of LII and 30 LIC was performed in BALB/c and Swiss Webster mice, as well the NOS and ARG 31 activities. The LII strain showed more infective than the LIC strain both in vivo and 32 in vitro. In animals infected by both strains, a difference in NOS and ARG activities 33 occurred. In vitro, promastigotes of LII isolated from BALB/c and Swiss Webster mice 34 showed higher ARG activity than the LIC during the growth curve, however, no 35 difference was observed in intracellular NO production by promastigotes between 36 these strains. A comparison of the sequences of the ARG gene was made and both 37 strains were identical. However, despite the similarity, the strains showed different 38 expression of this gene. It can be concluded that although L. chagasi strains are 39 considered identical to L. infantum strains, both have different biological behaviour. 40 41 Keywords: Leishmania species, L-arginine, arginase, nitric oxide synthase 42 43 3 47 attributed to them, which can manifest in various forms with different symptoms 48 depending on the infecting species and the host immune response. The main forms 49 of the disease are cutaneous, mucocutaneous and visceral leishmaniases (VL), the 50 latter being the most lethal manifestation with almost 0.5 million new cases each 51year, if not treated the mortality rate can reach 100% in two years [1,2] .
52Leishmania infantum is one of the species that causes VL and is present in 53 the Mediterranean Basin, as well as in the Middle East and South Asia. Some years 54 ago, L. chagasi was considered a new species of Leishmania causing visceral 55 leishmaniasis in the New World. However, after genetic sequencing studies, 56L. chagasi was considered identical to L. infantum, being denominated L. infantum 57 (syn. L. chagasi) [3] . Nevertheless, further studies showing antigenic differences 58 between both strains, they have considered as two subspecies L. infantum infantum 59 in the Old Wor...